Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Jan;38(1):357-61.
doi: 10.1128/JCM.38.1.357-361.2000.

Improved amplification of genital human papillomaviruses

P E Gravitt  1 , C L Peyton, T Q Alessi, C M Wheeler, F Coutlée, A Hildesheim, M H Schiffman, D R Scott, R J Apple
Affiliations

Improved amplification of genital human papillomaviruses

P E Gravitt et al. J Clin Microbiol. 2000 Jan.

Abstract

Genital human papillomaviruses (HPVs) are commonly detected from clinical samples by consensus PCR methods. Two commonly used primer systems, the MY09-MY11 (MY09/11) primers and the GP5+-GP6+ (GP5+/6+) primers, amplify a broad spectrum of HPV genotypes, but with various levels of sensitivity among the HPV types. Analysis of the primer-target sequence homology for the MY09/11 primers showed an association between inefficient amplification of HPV types and the number and position of mismatches, despite accommodation of sequence variation by inclusion of degenerate base sites. The MY09/11 primers were redesigned to increase the sensitivity of amplification across the type spectrum by using the same primer binding regions in the L1 open reading frame. Sequence heterogeneity was accommodated by designing multiple primer sequences that were combined into an upstream pool of 5 oligonucleotides (PGMY11) and a downstream pool of 13 oligonucleotides (PGMY09), thereby avoiding use of degenerate bases that yield irreproducible primer syntheses. The performance of the PGMY09-PGMY11 (PGMY09/11) primer system relative to that of the standard MY09/11 system was evaluated with a set of 262 cervicovaginal lavage specimens. There was a 91.5% overall agreement between the two systems (kappa = 0.83; P < 0.001). The PGMY09/11 system appeared to be significantly more sensitive than the MY09/11 system, detecting an additional 20 HPV-positive specimens, for a prevalence of 62.8% versus a prevalence of 55.1% with the MY09/11 system (McNemar's chi(2) = 17.2; P < 0.001). The proportion of multiple infections detected increased with the PGMY09/11 system (40. 0 versus 33.8% of positive infections). HPV types 26, 35, 42, 45, 52, 54, 55, 59, 66, 73, and MM7 were detected at least 25% more often with the PGMY09/11 system. The PGMY09/11 primer system affords an increase in type-specific amplification sensitivity over that of the standard MY09/11 primer system. This new primer system will be useful in assessing the natural history of HPV infections, particularly when the analysis requires HPV typing.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
HPV type-specific positive results with PGMY09/11 and MY09/11. The total number of positive results by HPV type are plotted: open bar, detected with MY09/11 only; shaded bar, detected with both primer sets; stippled bar, detected with PGMY09/11 only. The type-specific results include positive results for HPV types from specimens infected with both single and multiple HPV types.
See this image and copyright information in PMC

References

    1. Bauer H M, Greer C E, Manos M M. Determination of genital human papillomavirus infection using consensus PCR. In: Herrington C S, McGee J O D, editors. Diagnostic molecular pathology: a practical approach. Oxford, United Kingdom: Oxford University Press; 1992. pp. 132–152.
    1. Bernard H U, Chan S Y, Manos M M, Ong C K, Villa L L, Delius H, Peyton C L, Bauer H M, Wheeler C M. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis. 1994;170:1077–1085. - PubMed
    1. Breslow N E, Day N E. Statistical methods in cancer research. Vol. 1. 1980. Classical methods of analysis of matched data; pp. 164–166. The analysis of case control studies. IARC Scientific Publications No. 32. International Agency for Research on Cancer, Lyon, France.
    1. de Roda Husman A M, Walboomers J M, van den Brule A J, Meijer C J, Snijders P J. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol. 1995;76:1057–1062. - PubMed
    1. Fisher L D, van Belle G, editors. Biostatistics: a methodology for the health sciences. New York, N.Y: John Wiley & Sons, Inc.; 1993. Categorical data: contingency tables; pp. 256–259.

LinkOut - more resources